Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy.
Background: Prostate specific antigen (PSA) is an important biomarker to monitor the response to the treatment, but has not been fully utilized as a whole sequence. We used a longitudinal biomarker PSA to discover a new prognostic pattern that predicts castration-resistant prostate cancer (CRPC) aft...
| Publicado en: | BMC Medical Informatics & Decision Making Vol. 16; pp. 1 - 10 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research Journal Article |
| Publicado: |
BioMed Central
7/18/2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |